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1. Introduction 
For decades, cutaneous malignant melanoma (CMM) has been steadily increasing among 
indoor workers in industrialized countries around the world [Godar et al 2009; Godar 
submitted]. Scientists believe strong, intermittent UVB (290-320 nm) exposures, i.e., sunburn 
episodes, initiate CMM [Elwood et al 1985], and some believe the UVA (321-400 nm) passing 
through glass windows in offices and cars promotes it [Godar et al 2009]. In support of those 
possibilities exists the paradox between indoor and outdoor worker’s UV exposures and 
their incidences of CMM. Although outdoor workers get three to ten times the annual UV 
doses that indoor workers get [Godar et al 2001; Godar 2005], they have similar or lower 
incidences of CMM [Gandini et al 2005; Kennedy et al 2003].   
To understand what factor(s) may be responsible for the increasing incidence of CMM 
among indoor workers, we must know the temporal incidence by region around the world, 
especially by latitude [Godar, In press]. The causative agent of CMM is probably UVB-
initiated sunburn episodes [Elwood et al 1985], but the promoting agent is unknown and 
may be UVA passing through office windows and cars [Godar et al 2009], and earlier 
(<1988) through UVB-absorbing sunscreens [Gorham et al 2007]. However, there could be a 
different promoting agent or an additional promoting agent; whatever the promoting 
agent(s) are, they must have entered and/or left our environment years before the first 
observed increase in Connecticut, USA in 1935 [EPA 1987; Rousch et al  1988].  
We can analyze the CMM incidences of indoor working, industrialized populations over 
time and by latitudinal regions to get clues to the nature of the promoting agent(s).  In this 
book chapter, we will explore the incidence of CMM all over the world during two decades, 
1980 and 2000, by latitudinal regions of each fair-skinned continent: Europe, North America, 
and Australia (including New Zealand).  
2. Analysis methods 
We can obtain the CMM incidence data for Australia, New Zealand, USA, Canada, and 
Europe from the International Agency for Research on Cancer (IARC) [Doll et al 1966; Doll 
et al 1970; Waterhouse et al 1976; Waterhouse et al 1982; Muir et al 1987; Parkin et al 1992; 
Parkin et el 1997; Parkin et al 2002; Curado et al 2007].  
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We can average the CMM incidence data of IARC from the following regions for the years 
1980 and 2000 to get mean latitudes or latitudinal ranges for each region in a country or 
continent: 
1. Northern Europe (~65°N; range ~60-70°N) – Iceland, Norway, Sweden, and Finland, 
2. Middle Europe (~55°N, <20°E; range ~50-60°N) – Ireland, Northern Ireland, Scotland, 
England, Denmark, the Netherlands, Belgium, and Germany, and either includes or 
excludes the following countries ≥20°E: Poland, Estonia, Latvia, Lithuania, and Belarus, 
3. Southern Europe (~45°N; range 40-50°N) – France, Switzerland, Austria, Czech 
Republic, Slovakia, and Croatia, and either includes or excludes countries with 
predominately skin types ≥III: Portugal, Spain and Italy, 
4. British Isles data from the year 2000 for the following regions (~53°N, range ~51-56°N): 
(~54.5°N) Scotland, Northern Ireland, Northern and Yorkshire, (~53.5°N) Ireland, North 
Western, Merseyside and Cheshire, Trent; (~52.5°N) West Midlands, East Anglia; 
(~51.5°N) South and Western, Oxford, and Thames, 
5. Northernmost Canada and USA (~65°N; ~60-70°N) - Northwest Territories and Alaska, 
6. Northern Canada (~55°N; range ~50-60°N) – British Columbia, Alberta, Saskatchewan, 
Manitoba, and Ontario,  
7. Southern Canada (~45°N; range ~40-50°N)- Newfoundland and Quebec; Nova Scotia, 
New Brunswick, and Prince Edward’s Island,  
8. Northern USA (~45°N; range ~40-50°N) - Washington, Oregon, Idaho, Montana, Iowa, 
Wisconsin, Illinois, Indiana, Michigan, Ohio, Pennsylvania, District of Columbia, New 
Jersey, New York (excludes New York City), Vermont, Rhode Island, Massachusetts, 
and Maine (2000 yr data was not available for the other states: New Hampshire, 
Delaware, Maryland, North and South Dakota, Minnesota, Nebraska, Wyoming, and 
Nevada), 
9. Southern USA (~35°N; range ~30-40°N) - California, Arizona, Utah, Colorado, New 
Mexico, Oklahoma, Texas, Missouri, Louisiana, Kentucky, Alabama, Georgia, South 
Carolina, Virginia, and Florida (2000 yr data was not available for the other states: 
Kansas, Arkansas, Mississippi, Tennessee, and North Carolina);  
10. Southernmost USA (~20°N) - Hawaii, 
11. Southern Hemisphere - Australia - (~19°S) Townsville, Queensland; (range ~20-29°S) 
Queensland, Western, (32°S) South; (range 30-39°S) New South Wales, Capital 
Territory, Victoria; (range <39°S) Tasmania and New Zealand 
12. New Zealand 1980 regional plots - (~40.5°S; range 34.5-47°S) – (36°S) Northern, (38°S) 
Midland, (41°S) Central, and (44°S) Southern [regional values are from Bulliard et al 
1994], 
Figure 1 has averaged IARC data from numbers 1-3 above that either includes (circles) or 
excludes (squares) Eastern European and Southern European countries. Figure 2 has 
averaged IARC data from number 4 above. Figure 3 has averaged IARC data from numbers 
5-10 above. Figure 4 has averaged IARC data from number 11 above.  Figure 5 A and B have 
data from 12 above [Bulliard et al 1994]. 
3. Results  
Figure 1 shows the incidences of CMM in the year 2000 for Europe. The values shown were 
averaged by latitudinal ranges ~40-50°N (~45°N), ~50-60°N (~55°N) and >60°N (~65°N). 
The lines with circles in the figure represent all the available European data. The lines with 
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squares represent the European data with excluded Eastern European (>20°E) countries 
from latitudes 50°N to 60°N, i.e., Poland, Estonia, Lithuania, Belarus, Lithuania and Latvia, 
and excluded southern European countries from latitudes ~40°N that have predominately 
people with skin type III or more, i.e., Spain, Portugal and Italy. Excluding the Eastern 
European countries and the Southern European countries did not change the trend. The data 
shows a flat incidence rate of CMM from about 40°N to 55°N and then an increasing 
incidence with increasing latitude above that.   
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Fig. 1. The CMM incidences in the year 2000 for Europe averaged by latitudinal ranges ~40-
50°N (~45°N), ~50-60°N (~55°N) and >60°N (~65°N). The circles include all the data (see the 
Analysis section), while the squares exclude the Eastern European countries from latitudes 
50°N to 60°N, Poland, Estonia, Lithuania, Belarus, Lithuania and Latvia, and the countries 
with predominately skin types ≥III, i.e., Spain, Portugal and Italy. 
Figure 2 shows the CMM incidences in the year 2000 for the British Isles: Ireland, Northern 
Ireland, Scotland and regions in England. A minimum appears to occur around 53.5°N. 
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Fig. 2. The CMM incidences in the year 2000 for the British Isles: Ireland, Northern Ireland, 
Scotland and regions in England. 
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Figure 3 shows the CMM incidences in the year 2000 for North America: Canada and USA 
(includes Hawaii and Alaska).  The CMM incidence decreases with increasing latitude and 
are unlike the Western European incidences that increase with increasing latitude above 
~50°N.  
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Fig. 3. The CMM incidences in the year 2000 for North America: Canada and USA (includes 
Hawaii and Alaska).  
Figure 4 shows the CMM incidences in the years 1980 and 2000 for Australia by latitude. 
The CMM incidence decreases with increasing latitude until ~35°S where it appears to 
increase somewhat with increasing latitude in 2000. 
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Fig. 4. The CMM incidences in the years 1980 and 2000 for Australia by latitude. 
Figure 5A shows an exponential increasing incidence of CMM with latitude in the southern 
hemisphere. New Zealand by region (1980): Northern (36°S), Midland (38°S), Central (41°S), 
and Southern (44°N). Figure 5B shows the temporal exponential increase in the incidence of 
CMM from 1970 to 1985 in the different regions of New Zealand by latitude. There is an 
exponential increase in the incidence of CMM with increasing latitude and an exponential 
increase in the incidence of CMM over time as well. 
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Fig. 5. A) Exponential increasing incidence of CMM with latitude in the southern 
hemisphere. New Zealand (1980) by region: Northern (36°S), Midland (38°S), Central (41°S), 
and Southern (44°N). B) The temporal exponential increase in the incidence of CMM from 
1970 to 1985 in different regions of New Zealand by latitude. 
4. Discussion 
The incidences of CMM in fair-skinned, indoor-working people have been steadily 
increasing in industrialized nations worldwide for decades (Godar et al 2009; Godar 
submitted). The regions of the world with the lowest CMM incidences are in Southern and 
Middle Europe ~40-60°N whether or not Eastern and Southern European countries  
are included or excluded from the analysis (Figure 1). However, regional data for the  
British Isles begins to show an increasing incidence with increasing latitude around 53.5°N 
(Figure 2).  
That trend is counterintuitive because the amount of UVB present in the terrestrial spectrum 
decreases with increasing latitude, suggesting something else must be increasing the 
incidence of CMM with increasing latitude.  Separate analysis of the data for the Eastern 
European countries, Poland, Estonia, Latvia, Lithuania including Saint Petersburg, Russia, 
gives an incidence of 4.73 (4.82 if Russia is excluded) half the value of Western European 
countries, which may be due to socio-economic status and/or vacation choices. In North 
America, there is clearly an increasing incidence of CMM with decreasing latitude (Figure 
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3); one does not observe the same trend as seen in Europe where an inversion in the 
incidence of CMM occurs near 53°N. Unlike Europe, the trend in North America continues 
to decrease with increasing latitude. This may be due to a cultural difference between 
Northern Europeans and Northern Canadians and Alaskans because we know Northern 
Europeans tend to take extended vacations at lower latitudes, e.g., Mediterranean.  At lower 
latitudes, they can get sunburned to initiate CMM and then return to their country above 
50°N, where there is more UVA relative to UVB, to promote CMM growth the rest of the 
year. We obtain a clue that vacation choice might be responsible by analyzing the southern 
Hemisphere data for the years 1980 and 2000 (Figure 4), where during 1980 we see a similar 
trend as observed in North America in the year 2000, but the trend changes to what we see 
in Europe in the year 2000. This upward change in the CMM trend for the lower latitudinal 
regions may be due to increased air travel over the decades leading to more people 
vacationing closer to the sunny equator. In 1980, New Zealanders displayed an exponential 
increasing incidence of CMM with increasing latitude (Figure 5A) that increased 
exponentially over time (Figure 5B). However, the temporal exponential increase with 
latitude is not only true of New Zealand but is also true for some other countries and 
regions around the world.  
Whether the incidence of CMM is increasing exponentially or not does not change the  
fact that it is increasing at an alarming rate each year. In order to slow or stop this  
increasing trend, we must know what is causing it and, if possible, change it. We know 
whatever started the increasing incidence of CMM either entered or left our environment 
before 1935, because that is when we have documented data for the first increases in  
CMM in the USA (Godar et al 2009; Godar In Press). From that data, we know that nothing 
that came out after the increasing CMM trend began can be responsible for starting it. For 
example, fluorescent lights (~1938 (http://wweu.wikipedia.org/wiki/Fluorescent_lamp), 
sunscreens (early 1950’s for UVB absorbing and in 1988 for UVA and UVB absorbing; 
http://en.wikipedia.org/wiki/Sunscreen), and tanning devices (~1978; 
http://en.wikipedia.org/wiki/Tanning_bed#History) all entered our environment after the 
increasing incidence of CMM was first documented in the USA back in 1935 [EPA, 1987; 
Rousch et al 1988]. Thus, we should analyze what happened before 1935, during the early 
20th century, in order to discover what might have affected the incidence of CMM. 
During the early 20th century, people in industrialized countries went against evolution by 
working indoors during the day. That action alone drastically decreased their daily amount 
of cutaneous vitamin D3 and simultaneously exposed them to only UVA radiation passing 
through glass windows in offices [Godar et al 2009] and cars [Moehrle et al 2003]. People 
created an artificial UV barrier with window glass that divides the UVB from the UVA, so 
that the vitamin D-making UVB wavelengths [MacLaughlin et al, 1982] were excluded while 
only the vitamin D-breaking [Webb et al 1989] and DNA-mutating UVA wavelengths [Peak 
and Peak 1991; Jones et al 1987; Halliday et al 2005] were included in our indoor-working 
environment. Possibly because this unnatural UV environment existed for decades in 
buildings and later in cars [Moehrle et al 2003], CMM was promoted by UVA, after being 
initiated by UVB sunburns, and began to steadily increase in the mid-1930’s or before.  
We also know the ratio of UVA to UVB increases with increasing latitude and that CMM 
increases with latitude above ~53°N. Evidently, people who live above 50°N go to the beach 
during the summer and get sunburned at lower latitudes, where they are unfamiliar with 
the sun’s intensity, to initiate CMM, and then they return home to northern latitudes that 
have primarily UVA for most of the year (inside as well as outside) to promote CMM. The 
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higher latitudes also allows the sun to aim more often at a perpendicular angle to the 
window glass where more UVA can pass through and directly expose people’s skin during 
their workday[Pope and Godar 2010]. Furthermore, above ~50°N there is little UVB to make 
cutaneous vitamin D3 most of the year [Webb et al 1988]. Above 37° N, a vitamin D3 
“winter” occurs from at least November to February, which extends to October and March 
at higher latitudes, when the dose-rate of UVB is too low to make any previtamin D3. In 
contrast, UVB exposure during peak hours occurs to some extent to outdoor workers during 
their workweek, so that they can maintain adequate levels of vitamin D3 in their skin and 
blood for most of the year.  The blood levels of vitamin D (measured as 25-hydroxyvitamin 
D in serum) in outdoor workers who get about five times the solar UV dose that indoor 
workers get is about twice as high as indoor workers [Devgun et al 1981]. Increased 
cutaneous vitamin D levels, and natural exposure to UVA and UVB together, might explain 
why outdoor workers have a lower incidence of CMM compared to indoor workers, 
although they get 3-10 times more UV exposure. 
The reason vitamin D3 is important for controlling CMM is because most melanoma cells 
can directly convert it to the hormone calcitriol [Reichrath et al 2007]. Calcitriol controls the 
growth rate [Eisman et al 1987; Colston et al 1981; Frampton et al 1983] and apoptotic cell 
death [Danielson et al 1998] of melanoma cells, while it also affects the immune system 
[Yang et al 1993a, b] and inhibits tumor promotion [Chida et al 1985]. Increased blood levels 
of vitamin D might be responsible for increasing the survival of melanoma patients who get 
regular, moderate sun exposures [Berwick et al 2005; Newton-Bishop et al 2011]. Thus, 
intermittent, strong UVB-induced sunburns may initiate CMM, while low cutaneous 
vitamin D levels and UVA-induced DNA damage may promote CMM. 
5. Conclusions 
The incidence of CMM is increasing at an alarming rate around the world in indoor working 
industrialized populations. In most regions of the world, the CMM incidence decreases with 
increasing latitude. However, in Europe the incidence appears flat up to ~50°N where it 
begins to increase with increasing latitude. This may occur because there is more UVA 
relative to UVB for most of the year at higher latitudes. Windows that allow UVA to enter 
our vitamin D-deprived indoor-working environments and cars may be partly responsible 
for the increasing incidence of CMM. If this is true, we can lower the incidence or the rate of 
increase by simply placing UV filters on our office and car windows to help reduce CMM 
worldwide. 
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